TFS CAPITAL LLC - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q2 2013$68,00035,2560.00%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q3 2013.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders